Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Prescient Therapeutics Ltd banner

Prescient Therapeutics Ltd
ASX:PTX

Watchlist Manager
Prescient Therapeutics Ltd Logo
Prescient Therapeutics Ltd
ASX:PTX
Watchlist
Price: 0.062 AUD -3.13% Market Closed
Market Cap: AU$65.2m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-17%
5Y
+21%
10Y
+198%
Liabilities
+
3Y
+271%
5Y
+259%
10Y
+621%
Equity
+
3Y
-32%
5Y
+2%
10Y
+156%

Balance Sheet Decomposition
Prescient Therapeutics Ltd

Balance Sheet
Prescient Therapeutics Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Jun-2002 Jun-2003 Jun-2004 Jun-2005 Jun-2006 Jun-2007 Jun-2008 Jun-2009 Jun-2010 Jun-2011 Jun-2012 Jun-2013 Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023 Jun-2024 Jun-2025
Assets
Cash & Cash Equivalents
2
0
0
2
1
1
2
1
1
1
0
0
4
1
10
8
5
10
7
16
12
6
10
7
Cash
0
0
0
0
0
1
2
1
1
1
0
0
0
0
0
0
0
0
7
16
12
2
4
7
Cash Equivalents
2
0
0
2
1
0
0
0
0
0
0
0
4
1
10
8
5
10
0
0
0
4
6
0
Short-Term Investments
0
1
4
3
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
4
0
Total Receivables
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
2
1
1
2
3
4
5
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
2
4
5
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
1
Total Current Assets
2
2
4
4
4
3
2
1
2
1
0
0
4
2
10
9
7
12
9
18
14
25
19
13
PP&E Net
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
1
3
3
3
3
3
3
3
3
3
2
2
Total Assets
2
N/A
2
-14%
4
+155%
4
+1%
4
-11%
3
-13%
2
-46%
1
-33%
2
+33%
1
-55%
0
-91%
0
N/A
5
N/A
5
-7%
14
+183%
12
-12%
10
-18%
15
+50%
12
-20%
21
+74%
18
-16%
28
+60%
20
-27%
15
-29%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
1
0
0
1
2
2
3
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
2
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
0
1
1
1
2
1
0
2
0
2
2
0
0
0
1
0
1
1
1
1
1
2
2
3
Long-Term Debt
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Liabilities
0
N/A
1
+51%
1
-25%
1
+165%
2
+24%
1
-12%
2
+14%
2
+7%
1
-28%
2
+19%
2
+21%
0
N/A
0
N/A
0
+76%
1
+86%
0
-46%
1
+24%
1
+24%
1
+29%
1
-39%
1
+59%
2
+137%
2
+14%
3
+37%
Equity
Common Stock
13
16
23
26
30
32
32
33
35
35
36
36
43
44
54
55
56
64
64
77
77
93
93
94
Retained Earnings
12
15
19
23
28
30
32
33
35
36
38
36
37
40
41
44
46
50
53
57
61
67
76
83
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
1
N/A
1
-35%
4
+283%
3
-22%
2
-28%
2
-13%
0
-96%
1
N/A
0
N/A
1
N/A
2
-116%
0
N/A
5
N/A
4
-12%
13
+192%
12
-9%
9
-20%
14
+52%
11
-22%
20
+83%
17
-18%
26
+56%
18
-31%
11
-37%
Total Liabilities & Equity
2
N/A
2
-14%
4
+155%
4
+1%
4
-11%
3
-12%
2
-46%
1
-33%
2
+33%
1
-55%
0
-91%
0
N/A
5
N/A
5
-7%
14
+183%
12
-12%
10
-18%
15
+50%
12
-20%
21
+74%
18
-16%
28
+60%
20
-27%
15
-29%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
1
1
1
1
1
1
1
1
48
60
198
215
216
394
394
641
654
805
805
805

See Also

Summary
PTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
PTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PTX stock valuation using valuation multiples.
Wall Street Estimates
PTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.